Market Leadership McCreadie Group has been recognized as the top clinical trial pharmacy software in 2025, demonstrating strong industry credibility and market presence, which can be leveraged for upselling integrated software solutions or expanded service offerings.

Strategic Partnerships The company’s long-standing collaboration with the American Society of Health System Pharmacists and partnerships with Yale New Haven Hospital and Reveles Clinical Services highlight opportunities to tailor solutions for academic institutions, research centers, and clinical networks.

Innovation Focus With flagship products like PharmAcademic™ and Vestigo® that automate and improve research pharmacy operations, there is potential to expand into new research management tools and compliance solutions for organizations focused on drug discovery and clinical trials.

International Expansion Vestigo® is already expanding internationally, offering a growth avenue by targeting global research institutions and organizations aiming to enhance investigational drug services with automated, compliant software.

Growth Potential With a revenue range of $10 to $25 million and a focused niche in healthcare research tech, McCreadie Group presents opportunities to introduce scalable solutions for mid-sized health systems and research entities looking to modernize their pharmacy management capabilities.